![](https://qtxasset.com/quartz/qcloud5/media/image/FDA_0.jpg?VersionId=pTFwZPyDp6M2LM1XkvA8_P.NFmj6ERLC)
FDA approves Ono's rare tumor drug from $2.4B Deciphera buyout
A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. Fellow Japanese drugmaker Ono Pharmaceutical has won an FDA green light for vimseltinib for adult patients with symptomatic tenosynovial giant cell tumor (TGCT), …